Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PBMs Would Compete For Medicare Enrollees Under Sen. Roth's Rx Drug Plan

Executive Summary

Medicare would contract with multiple pharmaceutical benefit managers in each service area under Sen. Roth's (R-Del.) Medicare reform plan.

You may also be interested in...



Medicare Rx Debate Moves To Center Of Presidential Campaigns

The outcome of House/Senate negotiations over drug re-importation and taxpayer funded research will be the most pressing pharmaceutical-related issues in Washington, D.C., as the Medicare drug benefit debate takes center stage in the Presidential campaign.

Medicare Rx Debate Moves To Center Of Presidential Campaigns

The outcome of House/Senate negotiations over drug re-importation and taxpayer funded research will be the most pressing pharmaceutical-related issues in Washington, D.C., as the Medicare drug benefit debate takes center stage in the Presidential campaign.

Medicare Rx Mark-Up By Senate Finance Delayed Until After Recess

The Senate Finance Committee will not mark up Medicare reform legislation that would establish a prescription drug benefit until after the August congressional recess.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS036427

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel